Results 81 to 90 of about 6,301 (229)

Clinical factors associated with non-compliance with indicators of prescribed and infused volume of enteral nutrition therapy [PDF]

Objective: to evaluate the factors associated with non-compliance with the Quality Indicators in Nutritional Therapy (QINT) related to the prescribed and infused volume of Enteral Nutritional Therapy (ENT).
Stamm,Bruna, Assis,Michelli Cristina Silva de, Matsuba,Cláudia Satiko Takemura, Beghetto,Mariur Gomes   +3 more
core  

Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors

, 2023
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that are widely used for the management of many solid-organ and hematologic cancers. These agents work by inhibition of cytotoxic T-lymphocyte–associated antigen-4 (CTLA-4), programmed cell ...
Alexander Malik, Yousaf, Muhammad Nadeem, Veysel Tahan, Muhammad Nadeem Yousaf, Tahan, Veysel, Sami Samiullah, Malik, Alexander, Mahdi, Amin, Amin Mahdi, Samiullah, Sami   +9 more
core   +1 more source

Relación entre autocuidado y automedicación en estudiantes de ciencias de salud de una universidad pública

NURE Investigación
Objetivo. Analizar la prevalencia de la automedicación y su relación con la capacidad de autocuidado en estudiantes del Centro de Ciencias de la Salud de una universidad pública. Metodología.
Arely Paulina Diaz Nieves, Itzel de Lourdes Vega Quesada, Maria Isabel Martinez Moya, Ramiro Altamira Camacho   +3 more
doaj   +1 more source

Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024

Revista de Gastroenterología de México (English Edition)
Introduction: The aim of this position statement is to provide health professionals with an updated and evidence-based guideline for the pharmacologic management of irritable bowel syndrome (IBS) in Mexico.
J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, M.E. Icaza-Chávez, A. López-Colombo, E.C. Morel-Cerda, M.Á. Valdovinos-Díaz, L.R. Valdovinos-García, A.S. Villar-Chávez   +13 more
doaj   +1 more source

New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation

, 2016
The cystic fibrosis transmembrane conductance regulator (CFTR) is an unusual ABC transporter, functioning as a chloride channel critical for fluid homeostasis in multiple organs. Disruption of CFTR function is associated with cystic fibrosis making it an
Maya Schushan (132165), Nir Ben-Tal (9881), Ori Kalid (1773172), James Dalton (2062162), Jordi Villà-Freixa (2062159)   +4 more
core   +1 more source

The Design, Construction, and Testing of Nucleic Acid Vaccines Against Salmonella Enterica Subspecies Enterica Serovar Javiana [PDF]

Salmonella spp. is a Gram-negative bacterium that has the ability to replicate within a variety of hosts, or within the environment, including water, soil, and vegetation.
Nguyen, Alexis A
core   +1 more source

Racecadotril : A Novel Antidiarrheal [PDF]

Medical Journal Armed Forces India, 2008
N, Singh, S, Narayan
openaire   +2 more sources

Community Pharmacists' Knowledge in Managing Minor Ailments: A Focus on Childhood Gastroenteritis in Saudi Arabia Using a Simulated Patient Approach. [PDF]

Healthcare (Basel)
Background: Community pharmacists are frequently approached by patients seeking health advice for minor ailments, particularly for common childhood diseases like diarrhea. Globally, approximately two million children under five years of age die each year
Fadil HA, Khojah HMJ, Alzahrani F, Habeeb EA, Elshafie RM.   +4 more
europepmc   +2 more sources

Pharmacologic considerations in the treatment of neonatal septicemia and its complications

This article focuses on the pharmacologic properties of drugs commonly used in the treatment of neonatal septicemia and its complications. Rational therapy demands an awareness of not only the pharmacology of individual drugs but also the interactions ...

core   +1 more source

Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB).

, 2020
Background: Tucatinib (TUC) is an investigational TKI, highly selective for HER2 without significant inhibition of EGFR. HER2CLIMB is a randomized trial of TUC vs placebo in combination with trastuzumab and capecitabine in patients (pts) with HER2 ...
Valdes, Frances, Pluard, Timothy J., Okines, Alicia Frances Claire, Conlin, Alison, Krop, Ian E., Slamon, Dennis J., Specht, Jennifer M, Okines, Alicia Frances Clare, Jakobsen, Erik, An, Grace, Sutherland, Stephanie, Lustberg, Maryam B, Paplomata, Elisavet, Wright, Gail Lynn Shaw, Hamilton, Erika Paige, Gelmon, Karen A, Conlin, Alison Katherine, Wahl, Tanya A., Chan, Arlene, Lustberg, Maryam B., Slamon, Dennis J, Gelmon, Karen A., Ramos, Jorge, Wahl, Tanya, Pluard, Timothy J, Clark, Amy Sanders, Zhu, Xiaofu, Specht, Jennifer M., Krop, Ian E   +28 more
core   +1 more source